• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/10/21 9:00:51 AM ET
    $SCPE
    Business Services
    Finance
    Get the next $SCPE alert in real time by email
    SC 13G/A 1 formsc13ga.htm FORM SC 13G/A Polar Asset Management Partners Inc.: Form SC 13G/A - Filed by newsfilecorp.com

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G/A

    Under the Securities Exchange Act of 1934

    (Amendment No. 3)*

    SC Health Corporation

    (Name of Issuer)
      

    Class A Ordinary Shares, par value $0.0001 per share

    (Title of Class of Securities)
       

    G78516203

    (CUSIP Number)
      

    December 31, 2020

    (Date of Event which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     [X]  Rule 13d-1(b)

     [_]  Rule 13d-1(c)

     [_]  Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


    CUSIP No. G78516203

    13G/A

    Page 2 of 5 Pages


    1

    Names of Reporting Persons

    Polar Asset Management Partners Inc.

    2

    Check the appropriate box if a member of a Group (see instructions)

    (a)  [ ]
    (b)  [ ]

    3

    Sec Use Only

     

    4

    Citizenship or Place of Organization

    Canada

    Number of Shares Beneficially Owned by Each Reporting Person With:

     

    5

    Sole Voting Power

    891,391

    6

    Shared Voting Power

     

    7

    Sole Dispositive Power

    891,391

    8

    Shared Dispositive Power

     

    9

    Aggregate Amount Beneficially Owned by Each Reporting Person

    891,391

    10

    Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    [ ]

    11

    Percent of class represented by amount in row (9)

    5.17%

    12

    Type of Reporting Person (See Instructions)

    IA


    Page 2 of 5


    CUSIP No. G78516203

    13G/A

    Page 3 of 5 Pages

    Item 1. 

    (a) Name of Issuer:

     The name of the issuer is SC Health Corporation (the "Company").

    (b) Address of Issuer's Principal Executive Offices:

    The Company's principal executive offices are located at 108 Robinson Road #10-00, Singapore  068900.

    Item 2. 

    (a) Name of Person Filing:

    This statement is filed by Polar Asset Management Partners Inc., a company incorporated under the laws of Ontario, Canada, which serves as the investment advisor to Polar Multi-Strategy Master Fund, a Cayman Islands exempted company ("PMSMF") with respect to the Shares (as defined below) directly held by PMSMF.

    (b) Address of Principal Business Office or, if None, Residence: 

    The address of the business office of the Reporting Person is 401 Bay Street, Suite 1900, PO Box 19, Toronto, Ontario M5H 2Y4, Canada.

    (c) Citizenship:

    The citizenship of the Reporting Person is Canada.

    (d) Title and Class of Securities:

    Class A Ordinary Shares, par value $0.0001 per share (the "Shares").

    (e) CUSIP No.:

    G78516203

    Item 3.  If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

    (a) [_] Broker or dealer registered under Section 15 of the Act;

    (b) [_] Bank as defined in Section 3(a)(6) of the Act;

    (c) [_] Insurance company as defined in Section 3(a)(19) of the Act;

    (d) [_] Investment company registered under Section 8 of the Investment Company Act of 1940;

    (e) [_] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

    (f) [_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

    Page 3 of 5


    CUSIP No. G78516203

    13G/A

    Page 4 of 5 Pages

    (g) [_] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

    (h) [_] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

    (i) [_] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;

    (j) [X] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);

    (k) [_] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

    If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

    The Reporting Person is an investment fund manager, portfolio manager, exempt market dealer and commodity trading manager registered with the Ontario Securities Commission.

    Item 4. Ownership

    The percentages used herein are calculated based upon 17,250,000 Shares outstanding as at December 21, 2020 as disclosed in the Company's Preliminary Proxy Statement on Schedule 14A dated December 22, 2020, filed with the Securities and Exchange Commission on December 22, 2020.

    The information required by Items 4(a) - (c) is set forth in Rows 5 - 11 of the cover page for the Reporting Person and is incorporated herein by reference.

    Item 5. Ownership of Five Percent or Less of a Class.

    Not Applicable.

    Item 6. Ownership of more than Five Percent on Behalf of Another Person.

     See Item 2. PMSMF has the right to receive or the power to direct the receipt of dividends from or the proceeds from the sale of more than 5% of the Shares.

    Item 7. Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person.

     Not applicable.

    Item 8. Identification and classification of members of the group.

     Not applicable.

    Item 9. Notice of Dissolution of Group.

     Not applicable.

    Item 10. Certifications.

    Page 4 of 5


    CUSIP No. G78516203

    13G/A

    Page 5 of 5 Pages

    By signing below the Reporting Person certifies that, to the best of its knowledge and belief, (i) the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect and (ii) the foreign regulatory schemes applicable to investment fund managers and broker-dealers are substantially comparable to the regulatory schemes applicable to the functionally equivalent U.S. institutions. The Reporting Person also undertakes to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated:  February 10, 2021

    POLAR ASSET MANAGEMENT PARTNERS INC.

    /s/ Andrew Ma
    Name:  Andrew Ma
    Title:  Chief Compliance Officer.


    Page 5 of 5


    Get the next $SCPE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SCPE

    DatePrice TargetRatingAnalyst
    6/30/2021$20.00Outperform
    Northland Capital Markets
    More analyst ratings

    $SCPE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Rockley Photonics Unveils End-to-end Digital Health Monitoring Solution Based on Spectrophotometer-on-a-chip Sensing Module

      Comprehensive "clinic-on-the-wrist" integration combining hardware, application firmware, and cloud analytics will accelerate deployment for customers and partners. Rockley Photonics, a leading global silicon photonics technology company, today revealed its complete full-stack, "clinic-on-the-wrist" digital health sensor system. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210714005499/en/Wristband to be used in human studies (Photo: Business Wire) Rockley's sensor module and associated reference designs for consumer products integrate hardware and application firmware to enable wearable devices to monitor multiple biomarkers,

      7/14/21 7:00:00 AM ET
      $SCPE
      Business Services
      Finance
    • Rockley Photonics Accelerates Plan to Revolutionize Consumer Health and Wellness Monitoring by Going Public via SC Health Corp.

      OXFORD, United Kingdom & PASADENA, Calif.--(BUSINESS WIRE)--Rockley Photonics, Ltd. (“the Company” or “Rockley”), a leading global supplier of integrated silicon photonic chips and modules across multiple markets, today announced that it has entered into a definitive agreement to combine with SC Health Corp. (“SC Health”) (NYSE: SCPE), a publicly traded special purpose acquisition company. The transaction will result in Rockley becoming a publicly traded company on the NYSE under the symbol RKLY and values the Company at a pro forma enterprise value of $1.2 billion. Transforming healthcare through revolutionary “clinic-on-the-wrist” monitoring technology The transaction will accel

      3/19/21 7:00:00 AM ET
      $SCPE
      Business Services
      Finance
    • SC Health Corp. Enters into a Non-Binding Letter of Intent to Acquire a Next Generation Developer of Components & Modules for Consumer Health & Wellness Applications

      SINGAPORE--(BUSINESS WIRE)--SC Health Corp. (NYSE: SCPE) (the “Company”) announced today it has entered into a non-binding letter of intent (the “Letter of Intent”) with a next generation technology developer (the “Target”) for an initial business combination. The Target has developed a unique technology targeting consumer healthcare applications that delivers market-leading performance and accuracy. The Target is led by a world class management team with significant experience in leading innovative, high-growth companies in the sector. SC Health’s management team believes the Target is a compelling investment opportunity given its cutting-edge technology and commercial opportunity

      1/6/21 12:52:00 PM ET
      $SCPE
      Business Services
      Finance

    $SCPE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by SC Health Corporation (Amendment)

      SC 13G/A - SC Health Corp (0001764301) (Subject)

      8/9/21 10:45:12 AM ET
      $SCPE
      Business Services
      Finance
    • SEC Form SC 13G filed by SC Health Corporation

      SC 13G - SC Health Corp (0001764301) (Subject)

      7/19/21 4:37:01 PM ET
      $SCPE
      Business Services
      Finance
    • SEC Form SC 13G filed by SC Health Corporation

      SC 13G - SC Health Corp (0001764301) (Subject)

      7/19/21 9:38:11 AM ET
      $SCPE
      Business Services
      Finance

    $SCPE
    SEC Filings

    See more
    • SEC Form 15-12B filed by SC Health Corporation

      15-12B - SC Health Corp (0001764301) (Filer)

      8/23/21 5:15:16 PM ET
      $SCPE
      Business Services
      Finance
    • SC Health Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - SC Health Corp (0001764301) (Filer)

      8/13/21 12:25:44 PM ET
      $SCPE
      Business Services
      Finance
    • SEC Form 25-NSE filed by SC Health Corporation

      25-NSE - SC Health Corp (0001764301) (Subject)

      8/12/21 9:59:54 AM ET
      $SCPE
      Business Services
      Finance

    $SCPE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by SC Health Corporation

      4 - SC Health Corp (0001764301) (Issuer)

      8/13/21 12:20:52 PM ET
      $SCPE
      Business Services
      Finance
    • SEC Form 4: Llc Capital, Glazer sold $144,050 worth of Class A ordinary shares (13,400 units at $10.75)

      4 - SC Health Corp (0001764301) (Issuer)

      2/22/21 6:14:03 PM ET
      $SCPE
      Business Services
      Finance
    • SEC Form 4: Llc Capital, Glazer sold $1,307,194 worth of Class A ordinary shares (126,238 units at $10.36)

      4 - SC Health Corp (0001764301) (Issuer)

      1/20/21 7:12:25 PM ET
      $SCPE
      Business Services
      Finance

    $SCPE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Northland Capital Markets initiated coverage on SC Health with a new price target

      Northland Capital Markets initiated coverage of SC Health with a rating of Outperform and set a new price target of $20.00

      6/30/21 8:29:35 AM ET
      $SCPE
      Business Services
      Finance